SYDNEY--3 Jan-- ASTRAZENECA ANNOUNCES... ALDERLEY PARK: AstraZeneca has announced submission of a supplemental New Drug Application to the US Food and DrugAdministration to seek approval for a new indication for SEROQUEL (quetiapine fumarate) for the treatment of patients with depressive episodes associated with bipolar disorder. http://www.astrazenecapressoffice.com http://www.dbsalliance.org/PDF/IntroBrochureC2.pdf http://www.dbsalliance.org/media/bipolarfacts.html SEVEN WONDERS... ZURICH: The Chairman of a panel of leading architectural experts has announced the 21 world's landmark sites which willtake part in the final stage of the race to become one of the New 7 Wonders of the World. http://www.n7w.com/download http://www.new7wonders.com AsiaNet is a consortium of leading news agencies distributing unedited, translated news releases for worldwide clients. Visit www.asianetnews.net for full-text versions.